The UK government is considering ways to raise the price of medicines used by the NHS in an attempt to prevent further ...

The executives at this VIP roundtable were encouraged to share their thoughts on how AI innovation has been accelerating in ...

The vending machines will start to roll out in Los Angeles in December and carry a range of drugs like antibiotics, asthma ...

Regeneron's Libtayo has become the first checkpoint inhibitor to be cleared by the FDA as an adjuvant treatment for adults ...

As one of Frontiers Health’s most recognisable faces (and voices), Jessica DaMassa, founder of WTF Health and long-time emcee of the conference, has had a front-row seat to the events evolution over ...

On the outskirts of the LSX conference in Boston last month, pharmaphorum editor-in-chief Jonah Comstock sat down with Eron Kelly, CEO of Concert AI, to discuss the work his Boston-based start-up is ...

Sanofi raised its interest in AlphaMedix when it bought a 16% stake in Orano Med, a subsidiary of French nuclear fuel company ...

A jury in a Los Angeles, California court has ordered the company to pay an eye-watering $966 million to the family of Mae ...

The FDA has approved Boehringer Ingelheim's nerandomilast as a treatment for idiopathic pulmonary fibrosis (IPF), giving the ...

The former director of the FDA's Center for Biologics Evaluation and Research (CBER), Peter Marks, has joined Eli Lilly as ...

Earlier this year at the American Society of Clinical Oncology (ASCO) Congress, pharmaphorum spoke with Redwood City, ...

Cidara Therapeutics is celebrating a major injection of funding from the US government that will be used to support the development of its experimental preventive therapy for influenza. The sizeable ...